Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 MARKET STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Key industry insights
• 2.3 MARKET SIZE ESTIMATION METHODOLOGY
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
    • 2.3.1.2 Approach 2: Customer-based market estimation
    • 2.3.1.3 Approach 3: Top-down approach
    • 2.3.1.4 Approach 4: Primary interviews
    • 2.3.1.5 Growth forecast
    • 2.3.1.6 CAGR projection
  • 2.3.2 TOP-DOWN APPROACH
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 MARKET SHARE ASSESSMENT
• 2.6 RESEARCH ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MICROFLUIDICS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER AND COUNTRY (2023)
• 4.3 MICROFLUIDICS MARKET, BY REGION
• 4.4 GEOGRAPHIC SNAPSHOT OF MICROFLUIDICS MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing requirement for point-of-care testing
    • 5.2.1.2 Rising technological advancements
    • 5.2.1.3 Increasing focus on data precision and accuracy
    • 5.2.1.4 Economic benefits associated with microfluidics
    • 5.2.1.5 Portability with microfluidic chip miniaturization
    • 5.2.1.6 Rising demand for effective sample analysis
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Stringent regulatory approval process
    • 5.2.2.2 Integration of microfluidics into current workflow
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emergence of 3D cell culture systems
    • 5.2.3.2 Growth potential of emerging economies
    • 5.2.3.3 Use of microfluidics in life sciences & pharmaceutical industries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Low adoption of microfluidic devices among end users
• 5.3 INDUSTRY TRENDS
  • 5.3.1 E-HEALTH DIAGNOSTICS
  • 5.3.2 INTEGRATION OF MICROFLUIDICS WITH 3D PRINTING
  • 5.3.3 R&D INVESTMENTS FOR PRODUCT DEVELOPMENT
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 THREAT OF NEW ENTRANTS
  • 5.4.2 THREAT OF SUBSTITUTES
  • 5.4.3 BARGAINING POWER OF SUPPLIERS
  • 5.4.4 BARGAINING POWER OF BUYERS
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.5.2 BUYING CRITERIA
• 5.6 REGULATORY LANDSCAPE
  • 5.6.1 NORTH AMERICA
    • 5.6.1.1 US
    • 5.6.1.2 Canada
  • 5.6.2 EUROPE
  • 5.6.3 ASIA PACIFIC
    • 5.6.3.1 Japan
    • 5.6.3.2 China
    • 5.6.3.3 India
  • 5.6.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.7 REIMBURSEMENT SCENARIO
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 VALUE CHAIN ANALYSIS
  • 5.9.1 RESEARCH & DEVELOPMENT
  • 5.9.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
  • 5.9.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
• 5.10 SUPPLY CHAIN ANALYSIS
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.12 IMPACT OF GEN AI ON MICROFLUIDICS MARKET
• 5.13 PATENT ANALYSIS
  • 5.13.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS
  • 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.14 TRADE ANALYSIS
  • 5.14.1 IMPORT DATA
  • 5.14.2 EXPORT DATA
• 5.15 TECHNOLOGY ANALYSIS
  • 5.15.1 KEY TECHNOLOGIES
    • 5.15.1.1 Biosensor elements
    • 5.15.1.2 Materials science
    • 5.15.1.3 Microfabrication
    • 5.15.1.4 Direct-writing
  • 5.15.2 COMPLEMENTARY TECHNOLOGIES
    • 5.15.2.1 MEMS
      • 5.15.2.1.1 Green microfluidics
      • 5.15.2.1.2 Microsensors/transducers
  • 5.15.3 ADJACENT TECHNOLOGIES
    • 5.15.3.1 3D inkjet printing
    • 5.15.3.2 Lab-on-fiber
• 5.16 KEY CONFERENCES & EVENTS
• 5.17 PRICING ANALYSIS
  • 5.17.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.17.2 AVERAGE SELLING PRICE TREND OF TOP 3 APPLICATIONS, BY KEY PLAYER
• 5.18 UNMET NEEDS/END-USER EXPECTATIONS IN MICROFLUIDICS MARKET
• 5.19 CASE STUDY ANALYSIS
  • 5.19.1 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
  • 5.19.2 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
  • 5.19.3 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
• 5.20 INVESTMENT & FUNDING SCENARIO

6 MICROFLUIDICS MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 MICROFLUIDICS-BASED DEVICES
  • 6.2.1 HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS TO PROPEL MARKET
• 6.3 MICROFLUIDIC COMPONENTS
  • 6.3.1 MICROFLUIDIC COMPONENTS, BY TYPE
    • 6.3.1.1 Microfluidic chips
      • 6.3.1.1.1 Chips to account for largest share of components market
    • 6.3.1.2 Flow & pressure sensors
      • 6.3.1.2.1 Utilization in lab diagnostics & research applications to drive market
    • 6.3.1.3 Flow & pressure controllers
      • 6.3.1.3.1 Cost-effectiveness and durability to boost demand
    • 6.3.1.4 Microfluidic valves
      • 6.3.1.4.1 Technological advancements to support market growth
    • 6.3.1.5 Micropumps
      • 6.3.1.5.1 Wide usage in drug delivery and glucose injections to fuel uptake
    • 6.3.1.6 Microneedles
      • 6.3.1.6.1 Miniscule size and painless patch application procedure to boost demand
    • 6.3.1.7 Other microfluidic components
  • 6.3.2 MICROFLUIDIC COMPONENTS, BY MATERIAL
    • 6.3.2.1 Silicon
      • 6.3.2.1.1 High precision and durability to boost demand
    • 6.3.2.2 Polymers
      • 6.3.2.2.1 Polymethyl Methacrylate (PMMA)
        • 6.3.2.2.1.1 Durable alternative to glass to fuel uptake
      • 6.3.2.2.2 Polydimethylsiloxane (PDMS)
        • 6.3.2.2.2.1 Limited compatibility with specific solvents and acids to limit market adoption
      • 6.3.2.2.3 Cyclic Olefin Copolymers
        • 6.3.2.2.3.1 Low water absorption and enhanced electrical insulation properties to boost demand
      • 6.3.2.2.4 Other polymers
    • 6.3.2.3 Glass
      • 6.3.2.3.1 High cost and brittleness to restrain market

7 MICROFLUIDICS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 IVD
  • 7.2.1 CLINICAL DIAGNOSTICS
    • 7.2.1.1 Growing focus on early disease detection to drive market
  • 7.2.2 POINT-OF-CARE TESTING (POCT)
    • 7.2.2.1 High uptake of lab-on-a-chip technologies to fuel uptake
  • 7.2.3 VETERINARY DIAGNOSTICS
    • 7.2.3.1 Detection of toxins in food through LOC systems to support market growth
• 7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH
  • 7.3.1 LAB ANALYTICS
    • 7.3.1.1 Proteomic analysis
      • 7.3.1.1.1 Utilization of lab-on-a-chip devices for therapeutic development to drive market
    • 7.3.1.2 Genomic analysis
      • 7.3.1.2.1 Growing focus on NGS and digital PCR to boost demand
    • 7.3.1.3 Cell-based assays
      • 7.3.1.3.1 Drug-screening for cross-reaction & toxicity testing to support market growth
    • 7.3.1.4 Capillary electrophoresis
      • 7.3.1.4.1 Growing applications for environmental monitoring and clinical diagnostics to fuel uptake
  • 7.3.2 MICRODISPENSING
    • 7.3.2.1 Suitability for low-viscosity applications to support market growth
  • 7.3.3 MICROREACTORS
    • 7.3.3.1 High uptake by leading companies for process optimization to fuel market
• 7.4 THERAPEUTICS
  • 7.4.1 DRUG DELIVERY
    • 7.4.1.1 Utilization of microneedles for painless and precise delivery to drive market
  • 7.4.2 WEARABLE DEVICES
    • 7.4.2.1 Integration of microfluidics-based wearable devices to support market growth

8 MICROFLUIDICS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS AND DIAGNOSTIC CENTERS
  • 8.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED EQUIPMENT AND FOCUS ON EARLY DISEASE DIAGNOSIS TO BOOST DEMAND
• 8.3 ACADEMIC & RESEARCH INSTITUTES
  • 8.3.1 INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
• 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.4.1 GROWING FOCUS ON BIOMARKER & DRUG DISCOVERY TO PROPEL MARKET

9 MICROFLUIDICS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 High healthcare expenditure and wide adoption of technologically advanced products to drive market
  • 9.2.3 CANADA
    • 9.2.3.1 Government funds and focus on research to support market growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Growing focus on proteomics & genomics research to drive market
  • 9.3.3 FRANCE
    • 9.3.3.1 Favorable government support for R&D to drive market
  • 9.3.4 UK
    • 9.3.4.1 Rising cases of chronic diseases and increasing demand for POC testing to boost demand
  • 9.3.5 ITALY
    • 9.3.5.1 Innovative development of microfluidic chips to boost demand
  • 9.3.6 SPAIN
    • 9.3.6.1 Growth in pharmaceutical industry to fuel uptake
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Growing focus on nanotechnology to drive market
  • 9.4.3 JAPAN
    • 9.4.3.1 High investments in academic research activities to propel market
  • 9.4.4 INDIA
    • 9.4.4.1 Increasing prevalence of CVD and diabetes to support market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Rising incidence of infectious diseases to fuel uptake
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Increasing R&D expenditure to drive growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increasing development of disease diagnostics kits to fuel uptake
  • 9.5.3 MEXICO
    • 9.5.3.1 Rising prevalence of chronic diseases to boost demand for POC testing
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Adoption of advanced microfluidic devices to support market growth
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 10.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET
• 10.4 REVENUE ANALYSIS
• 10.5 MARKET SHARE ANALYSIS BY KEY PLAYERS,2023
• 10.6 RANKING OF KEY MARKET PLAYERS
• 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.7.1 STARS
  • 10.7.2 EMERGING LEADERS
  • 10.7.3 PERVASIVE PLAYERS
  • 10.7.4 PARTICIPANTS
  • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.7.5.1 Company footprint
    • 10.7.5.2 Product footprint
    • 10.7.5.3 Application footprint
    • 10.7.5.4 End-user footprint
    • 10.7.5.5 Region footprint
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 RESPONSIVE COMPANIES
  • 10.8.3 DYNAMIC COMPANIES
  • 10.8.4 STARTING BLOCKS
  • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 10.8.5.1 Detailed list of key startup/SME players
    • 10.8.5.2 Competitive benchmarking of key emerging players/startups
• 10.9 COMPANY VALUATION & FINANCIAL METRICS
  • 10.9.1 FINANCIAL METRICS
  • 10.9.2 COMPANY VALUATION
• 10.10 BRAND/PRODUCT COMPARATIVE ANALYSIS
• 10.11 COMPETITIVE SCENARIO
  • 10.11.1 PRODUCT LAUNCHES & APPROVALS
  • 10.11.2 DEALS
  • 10.11.3 EXPANSIONS
  • 10.11.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 DANAHER CORPORATION
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 ILLUMINA, INC.
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches & approvals
      • 11.1.2.3.2 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 BIOMERIEUX
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches & approvals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 THERMO FISHER SCIENTIFIC INC.
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches & approvals
      • 11.1.4.3.2 Deals
      • 11.1.4.3.3 Expansions
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 ABBOTT LABORATORIES
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Key strengths
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 PARKER HANNIFIN CORP
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
  • 11.1.7 SMC CORPORATION
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches
  • 11.1.8 IDEX CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
  • 11.1.9 FORTIVE
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 PERKINELMER INC.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product launches
      • 11.1.10.3.2 Deals
  • 11.1.11 AGILENT TECHNOLOGIES, INC.
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Deals
      • 11.1.11.3.3 Expansions
  • 11.1.12 BIO-RAD LABORATORIES, INC.
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Product launches
      • 11.1.12.3.2 Deals
  • 11.1.13 BECTON, DICKINSON AND COMPANY
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Product launches & approvals
      • 11.1.13.3.2 Deals
      • 11.1.13.3.3 Expansions
  • 11.1.14 F. HOFFMANN-LA ROCHE LTD.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches & approvals
      • 11.1.14.3.2 Deals
  • 11.1.15 STANDARD BIOTOOLS
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Product launches & approvals
      • 11.1.15.3.2 Deals
  • 11.1.16 QUIDELORTHO CORPORATION
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Product approvals
      • 11.1.16.3.2 Deals
      • 11.1.16.3.3 Expansions
  • 11.1.17 HOLOGIC, INC.
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
    • 11.1.17.3 Recent developments
      • 11.1.17.3.1 Product approvals
      • 11.1.17.3.2 Deals
  • 11.1.18 AIGNEP S.P.A.
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Deals
  • 11.1.19 DOLOMITE MICROFLUIDICS
    • 11.1.19.1 Business overview
    • 11.1.19.2 Products offered
    • 11.1.19.3 Recent developments
      • 11.1.19.3.1 Product launches & approvals
      • 11.1.19.3.2 Deals
      • 11.1.19.3.3 Other developments
  • 11.1.20 ELVEFLOW
    • 11.1.20.1 Business overview
    • 11.1.20.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 NANOSTRING TECHNOLOGIES
  • 11.2.2 NORTIS INC.
  • 11.2.3 INNOVATIVE BIOCHIPS, LLC
  • 11.2.4 FLUIDIC ANALYTICS
  • 11.2.5 UFLUIDIX
  • 11.2.6 HORIBA
  • 11.2.7 MICRONIT B.V.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

List of Tables

• TABLE 1 MICROFLUIDICS MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 MICROFLUIDICS MARKET: STUDY ASSUMPTIONS
• TABLE 3 RISK ASSESSMENT: MICROFLUIDICS MARKET
• TABLE 4 PRODUCT LAUNCHES BY KEY PLAYERS, 2023
• TABLE 5 LIST OF UNIVERSITY STARTUPS IN MICROFLUIDICS MARKET
• TABLE 6 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES
• TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET
• TABLE 8 KEY BUYING CRITERIA FOR MICROFLUIDICS MARKET, BY MATERIAL
• TABLE 9 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
• TABLE 10 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
• TABLE 11 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES
• TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
• TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
• TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 19 MAJOR CPT CODES FOR DIAGNOSTICS TESTS IN US, 2023
• TABLE 20 MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM
• TABLE 21 APPLICATIONS OF ARTIFICIAL INTELLIGENCE-POWERED MICROFLUIDICS
• TABLE 22 LIST OF MAJOR PATENT INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
• TABLE 23 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 24 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019-2023 (USD THOUSAND)
• TABLE 25 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2023-2024)
• TABLE 26 AVERAGE SELLING PRICE OF MICROFLUIDICS MEDICINE EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
• TABLE 27 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER, 2023 (USD)
• TABLE 28 MICROFLUIDICS MARKET: CURRENT UNMET NEEDS
• TABLE 29 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
• TABLE 30 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
• TABLE 31 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
• TABLE 32 MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 33 MICROFLUIDICS-BASED DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 34 MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 35 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 36 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS
• TABLE 37 MICROFLUIDIC CHIPS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 38 FLOW & PRESSURE SENSORS OFFERED BY KEY PLAYERS
• TABLE 39 FLOW & PRESSURE SENSORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 FLOW & PRESSURE CONTROLLERS OFFERED BY KEY PLAYERS
• TABLE 41 FLOW & PRESSURE CONTROLLERS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 42 MICROFLUIDIC VALVES OFFERED BY KEY PLAYERS
• TABLE 43 MICROFLUIDIC VALVES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 44 MICROPUMPS OFFERED BY KEY PLAYERS
• TABLE 45 MICROPUMPS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 46 MICRONEEDLES OFFERED BY KEY PLAYERS
• TABLE 47 MICRONEEDLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 48 OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 49 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 50 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 51 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 52 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 53 PMMA-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 54 PDMS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 55 COC-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 56 OTHER POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 57 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 59 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 60 MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 61 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 62 MICROFLUIDICS MARKET FOR POCT, BY REGION, 2022-2029 (USD MILLION)
• TABLE 63 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 64 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 65 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2022-2029 (USD MILLION)
• TABLE 66 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 67 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 68 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 69 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 70 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 71 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 72 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 73 MICROFLUIDICS MARKET FOR MICROREACTORS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 74 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 75 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 76 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY REGION, 2022-2029 (USD MILLION)
• TABLE 77 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 78 MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 79 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 80 LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST
• TABLE 81 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 82 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 83 MICROFLUIDICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 84 NORTH AMERICA: MACROECONOMIC OUTLOOK
• TABLE 85 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 86 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 87 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 88 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 89 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 90 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 91 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 92 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 93 NORTH AMERICA: MICROFLUIDICS COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 94 NORTH AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 95 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 96 US: KEY MACROINDICATORS
• TABLE 97 US: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 98 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 99 US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 100 US: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 101 CANADA: KEY MACROINDICATORS
• TABLE 102 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 103 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 104 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 105 CANADA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 106 EUROPE: MACROECONOMIC OUTLOOK
• TABLE 107 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 108 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 109 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 110 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 111 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 112 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 113 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 114 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 115 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 116 POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 117 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 118 GERMANY: KEY MACROINDICATORS
• TABLE 119 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 120 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 121 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 122 GERMANY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 123 FRANCE: KEY MACROINDICATORS
• TABLE 124 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 125 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 126 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 127 FRANCE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 128 UK: KEY MACROINDICATORS
• TABLE 129 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 130 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 131 UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 132 UK: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 133 ITALY: KEY MACROINDICATORS
• TABLE 134 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 135 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 136 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 137 ITALY: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 138 SPAIN: KEY MACROINDICATORS
• TABLE 139 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 140 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 141 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 142 SPAIN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 143 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 144 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 145 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 146 REST OF EUROPE: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 147 ASIA PACIFIC: MACROECONOMIC INDICATORS
• TABLE 148 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 149 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 150 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 151 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 152 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 154 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 155 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 156 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 157 ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 159 CHINA: KEY MACROINDICATORS
• TABLE 160 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 161 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 162 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 163 CHINA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 164 JAPAN: KEY MACROINDICATORS
• TABLE 165 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 166 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 167 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 168 JAPAN: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 169 INDIA: KEY MACROINDICATORS
• TABLE 170 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 171 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 172 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 173 INDIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 174 AUSTRALIA: KEY MACROINDICATORS
• TABLE 175 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 176 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 177 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 178 AUSTRALIA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 179 SOUTH KOREA: KEY MACROINDICATORS
• TABLE 180 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 181 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 182 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 183 SOUTH KOREA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 184 REST OF ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 185 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 186 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 187 REST OF ASIA PACIFIC: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 188 LATIN AMERICA: MACROECONOMIC OUTLOOK
• TABLE 189 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 190 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 191 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 192 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 193 LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 194 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 195 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 196 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 197 LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 198 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 199 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 200 BRAZIL: KEY MACROINDICATORS
• TABLE 201 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 202 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 203 BRAZIL: MICROFLUIDICS COMPONENT MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 204 BRAZIL: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 205 MEXICO: KEY MACROINDICATORS
• TABLE 206 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 207 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 208 MEXICO: MICROFLUIDICS MARKET, MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 209 MEXICO: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 210 REST OF LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 211 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 212 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 213 REST OF LATIN AMERICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 214 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 215 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
• TABLE 216 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 217 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 218 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 219 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 220 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 221 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 222 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 223 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 224 MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 225 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 226 GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 227 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 228 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 229 GCC COUNTRIES: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 230 REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 231 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 232 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• TABLE 233 REST OF MIDDLE EAST & AFRICA: POLYMER-BASED MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 234 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
• TABLE 235 MICROFLUIDICS MARKET: DEGREE OF COMPETITION
• TABLE 236 MICROFLUIDICS MARKET: PRODUCT FOOTPRINT
• TABLE 237 MICROFLUIDICS MARKET: APPLICATION FOOTPRINT
• TABLE 238 MICROFLUIDICS MARKET: END-USER FOOTPRINT
• TABLE 239 MICROFLUIDICS MARKET: REGION FOOTPRINT
• TABLE 240 MICROFLUIDICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
• TABLE 241 MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
• TABLE 242 MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 243 MICROFLUIDICS MARKET: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 244 MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 245 MICROFLUIDICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
• TABLE 246 DANAHER CORPORATION: COMPANY OVERVIEW
• TABLE 247 DANAHER CORPORATION: PRODUCTS OFFERED
• TABLE 248 DANAHER CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 249 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 250 ILLUMINA, INC.: COMPANY OVERVIEW
• TABLE 251 ILLUMINA INC.: PRODUCTS OFFERED
• TABLE 252 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 253 ILLUMINA, INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 254 BIOMERIEUX: COMPANY OVERVIEW
• TABLE 255 BIOMERIEUX: PRODUCTS OFFERED
• TABLE 256 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 257 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 258 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
• TABLE 259 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 260 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 261 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 262 ABBOTT LABORATORIES: COMPANY OVERVIEW
• TABLE 263 ABBOTT LABORATORIES: PRODUCTS OFFERED
• TABLE 264 PARKER HANNIFIN CORP: COMPANY OVERVIEW
• TABLE 265 PARK HANNIFIN CORP: PRODUCTS OFFERED
• TABLE 266 SMC CORPORATION: COMPANY OVERVIEW
• TABLE 267 SMC CORPORATION: PRODUCTS OFFERED
• TABLE 268 SMC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 269 IDEX CORPORATION: COMPANY OVERVIEW
• TABLE 270 IDEX CORPORATION: PRODUCTS OFFERED
• TABLE 271 IDEX CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 272 FORTIVE: COMPANY OVERVIEW
• TABLE 273 FORTIVE: PRODUCTS OFFERED
• TABLE 274 PERKINELMER INC.: COMPANY OVERVIEW
• TABLE 275 PERKINELMER INC.: PRODUCTS OFFERED
• TABLE 276 PERKINELMER INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 277 PERKINELMER INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 278 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 279 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 280 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 281 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 282 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 283 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• TABLE 284 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
• TABLE 285 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 286 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
• TABLE 288 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
• TABLE 289 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 290 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 291 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 292 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
• TABLE 293 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
• TABLE 294 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 295 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW
• TABLE 297 STANDARD BIOTOOLS: PRODUCTS OFFERED
• TABLE 298 STANDARD BIOTOOLS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 299 STANDARD BIOTOOLS: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 300 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
• TABLE 301 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
• TABLE 302 QUIDELORTHO CORPORATION: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 303 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 304 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 305 HOLOGIC, INC.: COMPANY OVERVIEW
• TABLE 306 HOLOGIC, INC.: PRODUCTS OFFERED
• TABLE 307 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 308 HOLOGIC, INC: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 309 AIGNEP S.P.A.: COMPANY OVERVIEW
• TABLE 310 AIGNEP S.P.A.: PRODUCTS OFFERED
• TABLE 311 AIGNEP S.P.A.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 312 DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW
• TABLE 313 DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED
• TABLE 314 DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
• TABLE 315 DOLOMITE MICROFLUIDICS: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 316 DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
• TABLE 317 ELVEFLOW: COMPANY OVERVIEW
• TABLE 318 ELVEFLOW: PRODUCTS OFFERED
• TABLE 319 NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 320 NORTIS INC.: COMPANY OVERVIEW
• TABLE 321 INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW
• TABLE 322 FLUIDIC ANALYTICS: COMPANY OVERVIEW
• TABLE 323 UFLUIDIX: COMPANY OVERVIEW
• TABLE 324 HORIBA: COMPANY OVERVIEW
• TABLE 325 MICRONIT B.V.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 MICROFLUIDICS MARKET SEGMENTATION
• FIGURE 2 MICROFLUIDICS MARKET: RESEARCH DESIGN
• FIGURE 3 PRIMARY SOURCES
• FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 7 MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
• FIGURE 8 MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
• FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 10 TOP-DOWN APPROACH
• FIGURE 11 DATA TRIANGULATION
• FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 MICROFLUIDICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MICROFLUIDICS MARKET, 2024-2029
• FIGURE 17 GROWING DEMAND FOR POINT-OF-CARE TESTING TO DRIVE MARKET
• FIGURE 18 HOSPITALS AND DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE FOR JAPAN IN 2023
• FIGURE 19 NORTH AMERICA TO DOMINATE MICROFLUIDICS MARKET IN 2024
• FIGURE 20 CHINA TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 21 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 22 GLOBAL CANCER INCIDENCE, 2020-2040
• FIGURE 23 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDICS MARKET, BY MATERIAL
• FIGURE 25 KEY BUYING CRITERIA, BY MATERIAL
• FIGURE 26 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY
• FIGURE 27 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES IN CANADA
• FIGURE 28 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
• FIGURE 29 INDIA: REGULATORY PROCESS FOR IVD DEVICES
• FIGURE 30 MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS
• FIGURE 31 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 32 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS
• FIGURE 34 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2014-AUGUST 2024)
• FIGURE 35 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2021- 2023 (USD)
• FIGURE 36 AVERAGE SELLING PRICE OF TOP 3 APPLICATIONS, BY KEY PLAYER
• FIGURE 37 INVESTMENT & FUNDING SCENARIO, 2019-2023
• FIGURE 38 NUMBER OF INVESTOR DEALS, BY KEY PLAYERS, 2019-2023
• FIGURE 39 VALUE OF INVESTOR DEALS BY KEY PLAYERS, 2019-2023 (USD MILLION)
• FIGURE 40 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
• FIGURE 41 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
• FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2019-2023)
• FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2023)
• FIGURE 44 RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2023
• FIGURE 45 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 46 MICROFLUIDICS MARKET: COMPANY FOOTPRINT
• FIGURE 47 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 48 EV/EBITDA OF KEY VENDORS
• FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 50 MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 53 BIOMERIEUX: COMPANY SNAPSHOT (2023)
• FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
• FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
• FIGURE 56 PARKER HANNIFIN CORP: COMPANY SNAPSHOT (2023)
• FIGURE 57 SMC CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 58 IDEX CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 59 FORTIVE: COMPANY SNAPSHOT (2023)
• FIGURE 60 PERKINELMER INC.: COMPANY SNAPSHOT (2023)
• FIGURE 61 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 63 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
• FIGURE 64 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
• FIGURE 65 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023)
• FIGURE 66 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 67 HOLOGIC, INC.: COMPANY SNAPSHOT (2023)